1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-3640
  5. Product Images: Carvedilol

Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Carvedilol NDC 70518-3640 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

MM2 - Carvedilol 3.125mg 70518 3640 01

MM2 - Carvedilol 3.125mg 70518 3640 01

Carvedilol is a medication for which one tablet of 3.125 mg is available in the pack. The manufacturer of the medication is Aurohindo in Nagar, India. The medication should be kept out of the reach of children and stored at a temperature between 15-30°C (59-86°F). There are directions specified in the package insert for its usage. The medication was repackaged by RemedyRepack Inc. in Indiana, PA. The lot number, and expiration date are not available from the given text.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Carvedilol is a tablet medication with a strength of 3.125 mg, packaged in a box of 100 tablets by Aurohindo in Nagar, India. The medication is only available by prescription and should be kept out of reach of children. Instructions for use can be found in the package insert, and the medication should be stored at temperatures between 20-25°C (88-77°F), with temperature excursions permitted up to 15-30°C (59-86°F). This particular box of medication has been repackaged by RemedyRepack Inc. in Indiana, PA 15701. The expiration date and LOT number are not available from the provided information.*

Figure 1. Survival Analysis for COPERNICUS (Intent-to-Treat) - carvedilol fig1

Figure 1. Survival Analysis for COPERNICUS (Intent-to-Treat) - carvedilol fig1

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol fig2

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol fig2

This is a figure or graph showing the effects on mortality for different subgroups in COPERNICUS. The subgroups are categorized by gender, age, race, diabetic or non-diabetic, ischemic or non-ischemic, heart rate, blood pressure, and whether or not they were taking spironolactone. The hazard ratio is also shown. The figure shows the results for each subgroup at different time intervals.*

Figure 3. Survival Analysis for CAPRICORN (Intent-to-Treat) - carvedilol fig3

Figure 3. Survival Analysis for CAPRICORN (Intent-to-Treat) - carvedilol fig3

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig4

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig4

Chemical Structure - carvedilol str

Chemical Structure - carvedilol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.